Stylli Harry

CIK 00013293443 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001329344

Recent Transactions

50 trades

Tax Payment
BIORA THERAPEUTICS, INC.
Common Stock
2021-08-15$1.66/sh−10,335→ 14,816,522 total
Award
BIORA THERAPEUTICS, INC.
Common Stock
2021-04-15+229,885→ 14,826,857 total
Award
BIORA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2021-04-15+482,276→ 482,276 total
Award
BIORA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2021-03-15+185,823→ 185,823 total
Tax Payment
BIORA THERAPEUTICS, INC.
Common Stock
2021-02-15$5.60/sh−11,287→ 14,596,972 total
Tax Payment
BIORA THERAPEUTICS, INC.
Common Stock
2020-12-19$6.32/sh−8,615→ 14,608,259 total
Purchase
BIORA THERAPEUTICS, INC.
Common Stock
2020-12-02$3.27/sh+152,905→ 14,616,874 total
Purchase
BIORA THERAPEUTICS, INC.
Common Stock
2020-08-19$8.94/sh+10,000→ 14,463,969 total
Conversion
BIORA THERAPEUTICS, INC.
Series B Preferred Stock
2020-06-23−1,122,222→ 0 total
Conversion
BIORA THERAPEUTICS, INC.
Series A Preferred Stock
2020-06-23−4,120,000→ 0 total
Conversion
BIORA THERAPEUTICS, INC.
Common Stock
2020-06-23+202,080→ 14,453,969 total
Conversion
BIORA THERAPEUTICS, INC.
Common Stock
2020-06-23+13,213,254→ 14,251,889 total
Purchase
BIORA THERAPEUTICS, INC.
Common Stock
2020-06-19$15.00/sh+33,333→ 1,038,635 total
Award
BIORA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2020-02-05+478,148→ 478,148 total
Award
Molecular Insight Pharmaceuticals, Inc.
Stock Option (right to buy)
2010-05-13−25,000→ 25,000 total
Award
Molecular Insight Pharmaceuticals, Inc.
Stock Option (right to buy)
2009-05-12+25,000→ 25,000 total
Purchase
SEQUENOM INC
Common Stock
2009-03-13$13.44/sh+900→ 142,511 total
Purchase
SEQUENOM INC
Common Stock
2009-03-13$13.40/sh+400→ 140,911 total
Purchase
SEQUENOM INC
Common Stock
2009-03-13$13.43/sh+300→ 141,611 total
Purchase
SEQUENOM INC
Common Stock
2009-03-13$13.42/sh+400→ 141,311 total
Award
SEQUENOM INC
Restricted Stock Unit
2009-02-17+5,552→ 121,915 total
Purchase
SEQUENOM INC
Common Stock
2009-02-13$16.45/sh+600→ 131,411 total
Purchase
SEQUENOM INC
Common Stock
2009-02-13$16.55/sh+552→ 140,511 total
Purchase
SEQUENOM INC
Common Stock
2009-02-13$16.46/sh+500→ 131,911 total
Purchase
SEQUENOM INC
Common Stock
2009-02-13$16.54/sh+300→ 139,959 total
Purchase
SEQUENOM INC
Common Stock
2009-02-13$16.51/sh+1,200→ 139,659 total
Purchase
SEQUENOM INC
Common Stock
2009-02-13$16.48/sh+700→ 132,611 total
Purchase
SEQUENOM INC
Common Stock
2009-02-13$16.49/sh+300→ 132,911 total
Purchase
SEQUENOM INC
Common Stock
2009-02-13$16.44/sh+300→ 130,811 total
Purchase
SEQUENOM INC
Common Stock
2009-02-13$16.50/sh+5,548→ 138,459 total
Award
SEQUENOM INC
Non-Qualified Stock Option (right to buy)
2009-01-16+73,438→ 73,438 total
Award
SEQUENOM INC
Incentive Stock Option (right to buy)
2009-01-16+1,562→ 1,562 total
Purchase
SEQUENOM INC
Common Stock
2008-08-11$18.88/sh+910→ 121,352 total
Purchase
SEQUENOM INC
Common Stock
2008-08-11$18.92/sh+100→ 123,990 total
Purchase
SEQUENOM INC
Common Stock
2008-08-11$18.89/sh+390→ 122,290 total
Purchase
SEQUENOM INC
Common Stock
2008-08-11$18.90/sh+548→ 121,900 total
Purchase
SEQUENOM INC
Common Stock
2008-08-11$18.96/sh+2,367→ 129,242 total
Purchase
SEQUENOM INC
Common Stock
2008-08-11$18.86/sh+600→ 119,942 total
Purchase
SEQUENOM INC
Common Stock
2008-08-11$18.91/sh+1,600→ 123,890 total
Purchase
SEQUENOM INC
Common Stock
2008-08-11$18.93/sh+110→ 124,100 total
Purchase
SEQUENOM INC
Common Stock
2008-08-11$18.95/sh+775→ 126,875 total
Purchase
SEQUENOM INC
Common Stock
2008-08-11$18.94/sh+2,000→ 126,100 total
Purchase
SEQUENOM INC
Common Stock
2008-08-11$18.87/sh+500→ 120,442 total
Award
Molecular Insight Pharmaceuticals, Inc.
Stock Option (right to buy)
2007-06-26+25,000→ 25,000 total
Purchase
SEQUENOM INC
Common Stock
2007-05-09$3.51/sh+6,641→ 103,673 total
Purchase
SEQUENOM INC
Common Stock
2007-05-09$3.53/sh+100→ 103,773 total
Purchase
SEQUENOM INC
Common Stock
2007-05-09$3.49/sh+759→ 93,032 total
Purchase
SEQUENOM INC
Common Stock
2007-05-09$3.48/sh+2,000→ 92,273 total
Purchase
SEQUENOM INC
Common Stock
2007-05-09$3.50/sh+4,000→ 97,032 total
Purchase
SEQUENOM INC
Common Stock
2007-05-09$3.47/sh+1,500→ 90,273 total

Companies

Recent Filings

Address

MOLECULAR INSIGHT PHARMACEUTICALS, INC. 160 SECOND STREET

CAMBRIDGE, MA, 02142

View on SEC.gov